S. Korea's top pharmaceutical firms spend over 100 bln won each in H1 for R&D: data

South Korea's major pharmaceutical companies each invested more than 100 billion won in research and development during the first half of the year, according to data released in Seoul on August 23.

The spending figures highlight the ongoing financial commitment by the country's leading drug manufacturers toward innovation, drug discovery, and technological advancement within the competitive pharmaceutical sector.